Learn More
Medchemexpress LLC (E)-N-[4-(3-chloro-4-(3-fluorophenyl)methoxy)anilino]-4-(dimethylamino)but-2-enamide | 848133-17-5 | MFCD26792555 | >98.0% | 574.0 g/mol | C31H29ClFN5O3 | 10 MM 1 ML

Supplier: Medchemexpress LLC HY10344310MM 1ML
HKI-357 is an irreversible small-molecule inhibitor of EGFR and ERBB2 used as a research reagent to probe receptor autophosphorylation and downstream signaling pathways. It shows potent cellular activity (reported IC50s ~34 nM and 33 nM) and is provided as a solid or as a ready-to-use DMSO solution for cell signaling studies.
- Irreversible dual inhibitor of EGFR and ERBB2.
- Potent activity with IC50s around 34 nM and 33 nM.
- Suppresses EGFR autophosphorylation (Y1068) and downstream AKT and MAPK signaling.
- Available as 10 mM solution in DMSO or as solid quantities for flexible dosing.
- High purity, typically ≥98% (HPLC), suitable for research applications.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.